Is the combination of resmetirom and semaglutide useful for the treatment of metabolic dysfunction‐associated steatohepatitis?
Year: 2026
Type: article
Source: Diabetes Obesity and Metabolism
DOI: 10.1111/dom.70507
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7124958658
